Granata V, Fusco R, DAlessio V, Simonetti I, Grassi F, Silvestro L
Diagnostics (Basel). 2023; 13(2).
PMID: 36673019
PMC: 9858594.
DOI: 10.3390/diagnostics13020209.
Karagiannis E, Strouthos I, Leczynski A, Zamboglou N, Ferentinos K
Front Oncol. 2022; 12:800920.
PMID: 35299745
PMC: 8920984.
DOI: 10.3389/fonc.2022.800920.
Yao X, Yan D, Jiang X, Li X, Zeng H, Li H
World J Clin Cases. 2021; 9(7):1580-1591.
PMID: 33728301
PMC: 7942052.
DOI: 10.12998/wjcc.v9.i7.1580.
Yu T, Zhang W, Li C, Wang C, Gong G, Wang L
Abdom Radiol (NY). 2020; 45(11):3690-3697.
PMID: 32277241
DOI: 10.1007/s00261-020-02516-4.
Sayan M, Yegya-Raman N, Greco S, Gui B, Zhang A, Chundury A
Front Oncol. 2019; 9:345.
PMID: 31275846
PMC: 6591511.
DOI: 10.3389/fonc.2019.00345.
Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P
Oncologist. 2019; 24(10):e990-e1005.
PMID: 31217342
PMC: 6795153.
DOI: 10.1634/theoncologist.2018-0337.
Multiphysics modeling toward enhanced guidance in hepatic microwave ablation: a preliminary framework.
Collins J, Heiselman J, Clements L, Brown D, Miga M
J Med Imaging (Bellingham). 2019; 6(2):025007.
PMID: 31131291
PMC: 6527144.
DOI: 10.1117/1.JMI.6.2.025007.
Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.
Minami Y, Nishida N, Kudo M
Eur Radiol. 2019; 29(9):5045-5051.
PMID: 30963271
DOI: 10.1007/s00330-019-06189-6.
Contrast-enhanced ultrasound to ultrasound fusion during microwave ablation: feasibility study in a perfused porcine liver model.
Monsky W, Keravnou C, Averkiou M
J Ultrasound. 2019; 22(3):323-335.
PMID: 30811016
PMC: 6704228.
DOI: 10.1007/s40477-019-00366-5.
RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma.
Lencioni R, Cioni D
Hepat Oncol. 2018; 3(3):193-200.
PMID: 30191041
PMC: 6095431.
DOI: 10.2217/hep-2016-0005.
Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
Meijerink M, Puijk R, van Tilborg A, Henningsen K, Garcia Fernandez L, Neyt M
Cardiovasc Intervent Radiol. 2018; 41(8):1189-1204.
PMID: 29666906
PMC: 6021475.
DOI: 10.1007/s00270-018-1959-3.
Interventional radiofrequency ablation: A promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction.
Mizandari M, Kumar J, Pai M, Chikovani T, Azrumelashvili T, Reccia I
J Cancer. 2018; 9(4):629-637.
PMID: 29556320
PMC: 5858484.
DOI: 10.7150/jca.23280.
Clinical impact of cone beam computed tomography on iterative treatment planning during ultrasound-guided percutaneous ablation of liver malignancies.
Floridi C, Radaelli A, Pesapane F, Fumarola E, Lecchi M, Agostini A
Med Oncol. 2017; 34(6):113.
PMID: 28470535
DOI: 10.1007/s12032-017-0954-x.
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.
Ruers T, Van Coevorden F, Punt C, Pierie J, Borel-Rinkes I, Ledermann J
J Natl Cancer Inst. 2017; 109(9).
PMID: 28376151
PMC: 5408999.
DOI: 10.1093/jnci/djx015.
Computational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolization.
Pasciak A, Lin A, Georgiades C, Findeiss L, Kauffman S, Bradley Y
EJNMMI Res. 2016; 6(1):89.
PMID: 27957721
PMC: 5153383.
DOI: 10.1186/s13550-016-0244-1.
Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case-control comparative analysis.
Yu S, Yoon J, Lee J, Lee J, Kim S, Cho Y
Medicine (Baltimore). 2016; 95(35):e4551.
PMID: 27583865
PMC: 5008549.
DOI: 10.1097/MD.0000000000004551.
Thermal Radiofrequency Ablation as an Adjuvant Therapy for Patients With Colorectal Liver Metastasis.
Fan Y, Zhu X, Lan Q, Lou F, Zheng Y, Lou H
Oncol Res. 2016; 23(5):219-28.
PMID: 27098145
PMC: 7838751.
DOI: 10.3727/096504016X14567549091260.
Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.
Solorio L, Wu H, Hernandez C, Gangolli M, Exner A
Ther Deliv. 2016; 7(4):201-12.
PMID: 27010983
PMC: 5561990.
DOI: 10.4155/tde-2015-0008.
Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective.
Lencioni R, De Baere T, Martin R, Nutting C, Narayanan G
Liver Cancer. 2016; 4(4):208-14.
PMID: 26734576
PMC: 4698627.
DOI: 10.1159/000367747.
Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study.
Babawale S, Jensen T, Frokjaer J
World J Gastrointest Surg. 2015; 7(3):33-8.
PMID: 25848490
PMC: 4381154.
DOI: 10.4240/wjgs.v7.i3.33.